SESN Sesen Bio Inc

Eleven Biotherapeutics Inc is a biotechnology-based firm in the United States. It is engaged in the development of therapeutics to cure diseases related to the eye.

$2.36  +0.03 (1.07%)
As of 04/14/2021 15:59:37 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2014
Outstanding shares:  169,386,226
Average volume:  5,790,769
Market cap:   $394,669,907
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    817763105
ISIN:        US8177631053
Sedol:      BD254C3
Valuation   (See tab for details)
PE ratio:   -17.46
PB ratio:   13.87
PS ratio:   35.13
Return on equity:   242.73%
Net income %:   -199.33%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy